Recruiting
Phase 2

Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency

Sponsor:

Dana-Farber Cancer Institute

Code:

NCT03716739

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Testosterone Cypionate 100 MG/ML

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information